CIK 0001404644 · Non-accelerated filer<br>Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 980542593
- Phone
- (877) 237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- 8-K Event Results of operations
- 8-K Event Director nominations · Other events
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement
- 8-K Event Material agreement · Unregistered share sale · Other events
- 8-K/A Event Exhibits
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results · Other events
- 8-K Event Results of operations
- 8-K/A Event Exhibits
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events
- 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
- 10-K/A Report 10-K/A
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Agreement ended
- 8-K Event Results of operations
Page 6 of 9 · 178 filings